• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卡托普利可抑制72 kDa和92 kDa的基质金属蛋白酶。

Captopril inhibits the 72 kDa and 92 kDa matrix metalloproteinases.

作者信息

Sorbi D, Fadly M, Hicks R, Alexander S, Arbeit L

机构信息

Department of Medicine, SUNY at Stony Brook.

出版信息

Kidney Int. 1993 Dec;44(6):1266-72. doi: 10.1038/ki.1993.378.

DOI:10.1038/ki.1993.378
PMID:8301928
Abstract

Gelatinases are metalloproteinases in the kidney which can cleave type IV collagen as well as gelatin. We partially purified the 72 kDa and 92 kDa gelatinases. The gelatinolytic activity was measured by zymography and a quantitative biotin-avidin assay. By zymography, captopril in concentrations of 20 mM and 40 mM added to the incubation buffer reduced the gelatinolytic activity in a dose-dependent manner. The addition of zinc in a concentration of 50 to 100 microM reversed most of the inhibitory effect of captopril. By the biotin-avidin assay, captopril in a concentration of 30 to 50 nM reduced half of either the 72 kDa or 92 kDa gelatinolytic activity. Zinc in a concentration of 50 microM completely reversed the inhibitory effect of 1 microM captopril on both gelatinases. Lisinopril, a non-sulfhydryl ACE inhibitor, similarly inhibited the gelatinases, but a 100-fold higher concentration of the drug was needed. These findings suggest that captopril reversibly inhibits the 72 kDa and 92 kDa metalloproteinases by interacting with the zinc ion at their active sites. This inhibitory effect is observed with captopril levels comparable to the concentrations needed to inhibit the angiotensin converting enzyme in vivo and may at least partially explain some of the renoprotective effects seen with this drug.

摘要

明胶酶是肾脏中的金属蛋白酶,能够切割IV型胶原以及明胶。我们对72 kDa和92 kDa的明胶酶进行了部分纯化。通过酶谱法和定量生物素-抗生物素蛋白测定法测量明胶酶活性。通过酶谱法,向孵育缓冲液中添加浓度为20 mM和40 mM的卡托普利,明胶酶活性呈剂量依赖性降低。添加浓度为50至100 microM的锌可逆转卡托普利的大部分抑制作用。通过生物素-抗生物素蛋白测定法,浓度为30至50 nM的卡托普利可使72 kDa或92 kDa明胶酶活性降低一半。浓度为50 microM的锌可完全逆转1 microM卡托普利对两种明胶酶的抑制作用。赖诺普利,一种非巯基血管紧张素转换酶抑制剂,同样抑制明胶酶,但需要100倍更高浓度的药物。这些发现表明,卡托普利通过与72 kDa和92 kDa金属蛋白酶活性位点的锌离子相互作用,可逆地抑制这些酶。在体内,卡托普利抑制这些酶的浓度与抑制血管紧张素转换酶所需的浓度相当,这种抑制作用可能至少部分解释了该药物的一些肾脏保护作用。

相似文献

1
Captopril inhibits the 72 kDa and 92 kDa matrix metalloproteinases.卡托普利可抑制72 kDa和92 kDa的基质金属蛋白酶。
Kidney Int. 1993 Dec;44(6):1266-72. doi: 10.1038/ki.1993.378.
2
Captopril inhibits glioma cell invasion in vitro: involvement of matrix metalloproteinases.卡托普利在体外抑制胶质瘤细胞侵袭:基质金属蛋白酶的作用
Anticancer Res. 1995 Sep-Oct;15(5B):1985-9.
3
Captopril and lisinopril only inhibit matrix metalloproteinase-2 (MMP-2) activity at millimolar concentrations.卡托普利和赖诺普利仅在毫摩尔浓度时抑制基质金属蛋白酶-2(MMP-2)的活性。
Basic Clin Pharmacol Toxicol. 2014 Mar;114(3):233-9. doi: 10.1111/bcpt.12151.
4
Morphine modulates 72-kDa matrix metalloproteinase.
Am J Physiol. 1994 Oct;267(4 Pt 2):F654-9. doi: 10.1152/ajprenal.1994.267.4.F654.
5
Simulated glomerular pressure modulates mesangial cell 72 kDa metalloproteinase activity.模拟肾小球压力调节系膜细胞72 kDa金属蛋白酶活性。
Connect Tissue Res. 1996;33(4):257-63. doi: 10.3109/03008209609028883.
6
Nitric oxide stimulates the activity of a 72-kDa neutral matrix metalloproteinase in cultured rat mesangial cells.一氧化氮可刺激培养的大鼠系膜细胞中一种72 kDa中性基质金属蛋白酶的活性。
Biochem Biophys Res Commun. 1996 Jan 26;218(3):704-8. doi: 10.1006/bbrc.1996.0125.
7
Role of angiotensin converting enzyme in the vascular effects of an endopeptidase 24.15 inhibitor.血管紧张素转换酶在内肽酶24.15抑制剂血管效应中的作用。
Br J Pharmacol. 1995 Mar;114(6):1185-92. doi: 10.1111/j.1476-5381.1995.tb13332.x.
8
Captopril inhibits pp60(c-src) tyrosine phosphorylation in cultured human mesangial cells.卡托普利抑制培养的人系膜细胞中pp60(c-src)酪氨酸磷酸化。
Eur J Pharmacol. 1997 Oct 8;336(2-3):251-6. doi: 10.1016/s0014-2999(97)01250-8.
9
Characterization of angiotensin-converting enzyme in canine testis.犬睾丸中血管紧张素转换酶的特性研究
Reproduction. 2001 Jul;122(1):139-46.
10
Captopril inhibits glucose accumulation in retinal cells in diabetes.卡托普利可抑制糖尿病患者视网膜细胞中的葡萄糖积累。
Invest Ophthalmol Vis Sci. 2003 Sep;44(9):4001-5. doi: 10.1167/iovs.02-1193.

引用本文的文献

1
Cardioprotective Role of Captopril: From Basic to Applied Investigations.卡托普利的心脏保护作用:从基础研究到应用研究
Int J Mol Sci. 2025 Jul 25;26(15):7215. doi: 10.3390/ijms26157215.
2
Matrix Metalloproteinase-2 and CKD Progression: The Chronic Renal Insufficiency Cohort (CRIC) Study.基质金属蛋白酶-2与慢性肾脏病进展:慢性肾功能不全队列(CRIC)研究
Kidney Med. 2024 Jun 6;6(8):100850. doi: 10.1016/j.xkme.2024.100850. eCollection 2024 Aug.
3
The Association of Matrix Metalloproteinases with Chronic Kidney Disease and Peripheral Vascular Disease: A Light at the End of the Tunnel?
基质金属蛋白酶与慢性肾脏病和外周血管疾病的关系:隧道尽头的曙光?
Biomolecules. 2020 Jan 17;10(1):154. doi: 10.3390/biom10010154.
4
Role of MMP-2 and MMP-9 in resistance to drug therapy in patients with resistant hypertension.基质金属蛋白酶-2和基质金属蛋白酶-9在难治性高血压患者药物治疗抵抗中的作用。
Arq Bras Cardiol. 2015 Aug;105(2):168-75. doi: 10.5935/abc.20150060. Epub 2015 Jun 2.
5
Dose-modifying factor for captopril for mitigation of radiation injury to normal lung.卡托普利减轻正常肺辐射损伤的剂量调节因子。
J Radiat Res. 2012 Jul;53(4):633-40. doi: 10.1093/jrr/rrs004. Epub 2012 Jun 6.
6
Inhibition of matrix metalloproteinases protects mice from ascending infection and chronic disease manifestations resulting from urogenital Chlamydia muridarum infection.基质金属蛋白酶的抑制可保护小鼠免受泌尿生殖系统鼠衣原体感染导致的上行感染和慢性疾病表现。
Infect Immun. 2006 Oct;74(10):5513-21. doi: 10.1128/IAI.00730-06.
7
ACEI attenuates the progression of CCl4-induced rat hepatic fibrogenesis by inhibiting TGF-beta1, PDGF-BB, NF-kappaB and MMP-2,9.血管紧张素转换酶抑制剂通过抑制转化生长因子-β1、血小板衍生生长因子-BB、核因子-κB和基质金属蛋白酶-2、9来减轻四氯化碳诱导的大鼠肝纤维化进程。
World J Gastroenterol. 2005 Aug 21;11(31):4807-11. doi: 10.3748/wjg.v11.i31.4807.
8
Juxtaglomerular apparatus T-cell infiltration affects glomerular structure in Type 1 diabetic patients.球旁器T细胞浸润影响1型糖尿病患者的肾小球结构。
Diabetologia. 2004 Jan;47(1):82-8. doi: 10.1007/s00125-003-1253-y. Epub 2003 Nov 15.
9
Cardiac remodelling in end stage heart failure: upregulation of matrix metalloproteinase (MMP) irrespective of the underlying disease, and evidence for a direct inhibitory effect of ACE inhibitors on MMP.终末期心力衰竭中的心脏重塑:无论潜在病因如何,基质金属蛋白酶(MMP)均上调,且有证据表明血管紧张素转换酶抑制剂对MMP有直接抑制作用。
Heart. 2002 Nov;88(5):525-30. doi: 10.1136/heart.88.5.525.
10
Angiotensin-converting enzyme inhibitor captopril prevents activation-induced apoptosis by interfering with T cell activation signals.血管紧张素转换酶抑制剂卡托普利通过干扰T细胞活化信号来阻止活化诱导的细胞凋亡。
Clin Exp Immunol. 2000 Sep;121(3):515-22. doi: 10.1046/j.1365-2249.2000.01323.x.